Induction of bovine leukaemia virus Env-specific Th-1 type immunity in mice by vaccination with short synthesized peptide-liposome.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Vaccine

• Publication date

  1996-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0264-410X(96)00033-3PMID 8911011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The theory and practical application of adjuvants

  1995cited by this paper
• Oligomannose‐coated liposomes as an adjuvant for the induction of cell‐mediated immunity

  1995cited by this paper
• A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.

  1995cited by this paper
• T cell proliferative response to bovine leukaemia virus (BLV): identification of T cell epitopes on the major core protein (p24) in BLV-infected cattle with normal haematological values.

  1994cited by this paper
• Role of cell-mediated immunity in bovine leukemia virus (BLV) infection in ruminants: its implication for the vaccination strategy against retroviruses.

  1994cited by this paper
• Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70

  1993cited by this paper
• A strategy for prophylactic vaccination against HIV.

  1993cited by this paper
• A TH1-->TH2 switch is a critical step in the etiology of HIV infection.

  1993cited by this paper
• Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51

  1993cited by this paper
• Augmentation of Bovine Leukemia Virus (BLV)‐Specific Lymphocyte Proliferation Responses in Ruminants by Inoculation with BLV env‐Recombinant Vaccinia Virus: Their Role in the Suppression of BLV Replication

  1992cited by this paper
• Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells

  1992cited by this paper
• Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.

  1992cited by this paper
• Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity.

  1991cited by this paper
• Priming for in vitro and in vivo anti-human T lymphotropic virus type 1 cellular immunity by virus-related protein reconstituted into liposome.

  1991cited by this paper
• Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein

  1989cited by this paper
• Heterogeneity of cytokine secretion patterns and functions of helper T cells.

  1989cited by this paper
• Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals.

  1989cited by this paper
• Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

  1988cited by this paper
• Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.

  1988cited by this paper
• Experimental transmission of enzootic bovine leukosis to sheep: latency period of the tumoral disease.

  1988cited by this paper
• Protection against bovine leukemia virus infection in sheep by active and passive immunization.

  1986cited by this paper
• Complete nucleotide sequence of the AIDS virus, HTLV-III

  1985cited by this paper
• Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses.

  1985cited by this paper
• Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon

  1984cited by this paper
• The nucleotide sequence of the env gene and post-env region of bovine leukemia virus.

  1984cited by this paper
• Protection by vaccination against bovine leukemia virus infection in sheep.

  1984cited by this paper
• Evaluation of an inactivated bovine leukemia virus preparation as an immunogen in cattle.

  1978cited by this paper
• Liposomes as immunological adjuvants

  1974cited by this paper

• Characterization and application of recombinant Bovine Leukemia Virus Env protein

  2024cites this paper
• Dinámica de infección con el virus de la leucosis bovina en bovinos holando argentino portadores de genotipos definidos del gen bola drb3

  2018cites this paper
• Preventive and Therapeutic Strategies for Bovine Leukemia Virus: Lessons for HTLV

  2011cites this paper
• Diagnostic and immunoprophylactic applications of synthetic peptides in veterinary microbiology

  2009cites this paper
• Polysaccharides as carriers of bioactive agents for medical applications

  2008cites this paper
• , Ping Respiratory Syndrome Coronavirus Nucleocapsid Protein of Severe Acute Dominant Helper T-Cell Epitopes in the Identification and Characterization of

  2007cites this paper
• PHARMACEUTICALLY ENGINEERED NANOPARTICLES FOR ENHANCING IMMUNE RESPONSES TO HIV-1 TAT AND GAG p24 PROTEINS

  2006cites this paper
• The rapid quantitative analysis of bovine cytokine genes by real-time RT-PCR.

  2003cites this paper
• Delayed-type hypersensitivity in sheep induced by synthetic peptides of bovine leukemia virus encapsulated in mannan-coated liposome.

  2003cites this paper
• Protective effects of vaccination with bovine leukemia virus (BLV) Tax DNA against BLV infection in sheep.

  2003cites this paper
• Use of the Mannan Receptor to Selectively Target Vaccine Antigens for Processing and Antigen Presentation through the MHC Class I and Class II Pathways

  2002cites this paper
• Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization.

  2001cites this paper
• Host immune responses in the course of bovine leukemia virus infection.

  2001cites this paper
• Liposome encapsulation of a soluble recombinant fragment of the respiratory syncytial virus (RSV) G protein enhances immune protection and reduces lung eosinophilia associated with virus challenge.

  2000cites this paper
• Generation of cellular immune responses to antigenic tumor peptides

  2000cites this paper
• Up-regulation of tumor necrosis factor alpha mRNA is associated with bovine-leukemia virus (BLV) elimination in the early phase of infection.

  1999cites this paper
• Characterization of immune responses caused by bovine leukemia virus envelope peptides in sheep.

  1999cites this paper
• Chapter 8 – Synthetic peptides as vaccines

  1999cites this paper
• Theileria parasite infection in East Asia and control of the disease.

  1998cites this paper
• Control ofTheileria sergenti infection by vaccination

  1997cites this paper